Hypothalamo-pituitary sarcoidosis: A multicenter study of 24 patients

QJM: An International Journal of Medicine

Volumn 105, Issue 10, 2012, Pages 981-995

  Langrand, C ^a   Bihan, H ^b   Raverot, G ^a   Varron, L ^a   Androdias, G ^a   Borson Chazot, F ^a   Brue, T ^c   Cathebras, P ^d   Pinede, L ^e   Muller, G ^f   Broussolle, C ^a   Cotton, F ^a   Valeyre, D ^g   Seve, P ^a  

^a UNIVERSITÉ LYON 1   (France)

^b Department of Internal Medicine and Endocrinology ^*  (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL NORD   (France)

^e Infirmerie Protestante de Lyon   (France)

^f HÔPITAL DU BOCAGE   (France)

^g AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; GROWTH HORMONE; METHYLPREDNISOLONE; PREDNISONE; PROLACTIN; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES INSIPIDUS; FEMALE; FOLLOW UP; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS DISEASE; HYPOTHALAMOPITUITARY SARCOIDOSIS; HYPOTHALAMUS DISEASE; MALE; MEDICAL RECORD REVIEW; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SARCOIDOSIS; SCHOOL CHILD; TREATMENT OUTCOME;

EID: 84867134241     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcs121     Document Type: Article

References (31)

1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336:1224-34.
2. Lannuzzi MC, Rybicky BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357:2153-65.
3. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis 1990; 7:50-7.
4. Pietinalho A, Hiraga Y, Hosoda Y, Löfroos AB, Yamaguchi M, Selroos O. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis 1995; 12:61-7.
5. Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995; 52:875-9.
6. James DG, Sharma OP. Neurosarcoidosis. Proc R Soc Med 1967; 60(11 Part 1):1169-70.
7. Oksanen V. Neurosarcoidosis: clinical presentations and course in 50 patients. Acta Neurol Scand 1986; 73:283-90.
8. Lower EE, Weiss KL. Neurosarcoidosis. Clin Chest Med 2008; 29:475-92, ix.
9. James DG. Life-threatening situations in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15:134-9.
10. Sharma OP. Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 1997; 112:220-8.
11. Dumas JL, Valeyre D, Chapelon-Abric C, Belin C, Piette JC, Tandjaoui-Lambiotte H, et al. Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy. Radiology 2000; 214:411-20.
12. Freda PU, Post KD. Differential diagnosis of sellar masses. Endocrinol Metab Clin North Am 1999; 28:81-117, vi.
13. Bullmann C, Faust M, Hoffmann A, Heppner C, Jockenhövel F, Müller-Wieland D, et al. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur J Endocrinol 2000; 142:365-72.
14. Tabuena RP, Nagai S, Handa T, Shigematsu M, Hamada K, Ito I, et al. Diabetes insipidus from neurosarcoidosis: long-term follow-up for more than eight years. Intern Med 2004; 43:960-6.
15. Bihan H, Christozova V, Dumas J-L, Jomaa R, Valeyre D, Tazi A, et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamicpituitary disease in 9 patients and review of the literature. Medicine (Baltimore) 2007; 86:259-68.
16. Molina A, Mañá J, Villabona C, Fernández-Castañ er M, Soler J. Hypothalamic-pituitary sarcoidosis with hypopituitarism. Long-term remission with methylprednisolone pulse therapy. Pituitary 2002; 5:33-6.
17. Bell NH. Endocrine complications of sarcoidosis. Endocrinol Metab Clin North Am 1991; 20:645-54.
18. Stuart CA, Neelon FA, Lebovitz HE. Disordered control of thirst in hypothalamic-pituitary sarcoidosis. N Engl J Med 1980; 303:1078-82.
19. Winnacker JL, Becker KL, Katz S. Endocrine aspects of sarcoidosis. N Engl J Med 1968; 278:483-92.
20. American thoracic society. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160:736-55.
21. Zajicek JP, Scolding NJ, Foster O, Rovaris M, Evanson J, Moseley IF, et al. Central nervous system sarcoidosis-diagnosis and management. QJM 1999; 92:103-17.
22. Berkmen YM. Radiologic aspects of intrathoracic sarcoidosis. Semin Roentgenol 1985; 20:356-75.
23. DeRemee RA. Clinical aspects, diagnosis and therapy of sarcoidosis of the respiratory organs. Prax Klin Pneumol 1983; 37(Suppl 1):519-22.
24. Bihan H, Guillot H, Fysekidis M, Cohen R, Gille T, Nunes H, et al. Sarcoidosis: the involvement of anterior pituitary hormones is poorly recognized. Presse Medicale (Paris, France: 1983). 2012; April 16 (doi:10.1016/j.lpm.2012.01.038; epub ahead of print).
25. Bleish VR, Robbins SL. Sarcoid-like granulomata of the pituitary gland; a cause of pituitary insufficiency. AMA Arch Intern Med 1952; 89:877-92.
26. Chapelon C, Ziza JM, Piette JC, Levy Y, Raguin G, Wechsler B, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 1990; 69:261-76.
27. Trabelsi L, Mnif M, Rekik N, Kaffel N, Charf N, Mnif J, et al. MRI pituitary stalk abnormalities: aetiology aspects in 11 patients. Ann Endocrino 2006; 67:604-12.
28. Karagiannis A, Harsoulis F. Gonadal dysfunction in systemic diseases. Eur J Endocrinol 2005; 152:501-13.
29. Silverstein E, Friedland J, Lyons HA, Gourin A. Elevation of angiotensin-converting enzyme in granulomatous lymph nodes and serum in sarcoidosis: clinical and possible pathogenic significance. Ann NY Acad Sci 1976; 278:498-513.
30. Oksanen V. New cerebrospinal fluid, neurophysiological and neuroradiological examinations in the diagnosis and follow-up of neurosarcoidosis. Sarcoidosis 1987; 4:105-10.
31. Rubin MR, Bruce JN, Khandji AG, Freda PU. Sarcoidosis within a pituitary adenoma. Pituitary 2001; 4:195-202.